HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Male Selected Research

Lipoprotein(a)

10/2014No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Male Research Topics

Disease

7Hemophilia A (Haemophilia)
11/2020 - 08/2000
7Thrombosis (Thrombus)
01/2017 - 01/2004
3Thromboembolism
09/2010 - 10/2001
2Hemorrhage
12/2011 - 08/2000
2Stroke (Strokes)
09/2010 - 01/2004
1Protein C Deficiency
10/2014
1Heart Diseases (Heart Disease)
10/2014
1Protein S Deficiency (Deficiency, Protein S)
10/2014
1Hyperhomocysteinemia
10/2014
1Hemophilia B (Haemophilia B)
07/2012
1Venous Thrombosis (Deep-Vein Thrombosis)
09/2010
1Thrombasthenia (Glanzmann Thrombasthenia)
08/2006
1Venous Thromboembolism
06/2005
1Ischemic Stroke
01/2004
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2001
1Anemia
08/2001
1Infections
05/2001
1Iron Deficiencies
05/2001
1Activated Protein C Resistance (APC Resistance)
02/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2001

Drug/Important Bio-Agent (IBA)

3Factor VIII (Coagulation Factor VIII)IBA
11/2020 - 01/2010
3Anticardiolipin AntibodiesIBA
10/2014 - 01/2004
2Heparin (Liquaemin)FDA LinkGeneric
01/2017 - 12/2011
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
10/2014 - 06/2005
2AntithrombinsIBA
10/2014 - 10/2001
2Immunoglobulin G (IgG)IBA
06/2005 - 01/2004
2Phospholipids (Phosphatides)FDA LinkGeneric
06/2005 - 01/2004
2IronIBA
08/2001 - 05/2001
2Transferrin (beta 2 Transferrin)IBA
08/2001 - 05/2001
1factor V LeidenIBA
10/2014
1Prothrombin (Factor II)IBA
10/2014
1Lipoprotein(a)IBA
10/2014
1Thromboplastin (Tissue Factor)IBA
08/2012
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
08/2012
1ThrombinFDA Link
08/2012
1ARC19499IBA
08/2012
1Therapeutic UsesIBA
07/2012
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
07/2012
1TE 5IBA
12/2011
1von Willebrand FactorIBA
09/2011
1A-factor (Streptomyces)IBA
09/2011
1Enoxaparin (Lovenox)FDA LinkGeneric
09/2010
1Blood Group Antigens (Blood Groups)IBA
01/2010
1IsoantibodiesIBA
08/2006
1Immunoglobulin M (IgM)IBA
06/2005
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
06/2005
1AntibodiesIBA
06/2005
1Immunoglobulins (Immunoglobulin)IBA
01/2004
1Saccharated Ferric Oxide (Venofer)FDA Link
08/2001
1ErythropoietinFDA Link
08/2001
1Transferrin Receptors (Transferrin Receptor)IBA
05/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2001
1Ferritins (Ferritin)IBA
05/2001
1TESIBA
02/2001
1Antiphospholipid AntibodiesIBA
02/2001
1AnticoagulantsIBA
02/2001

Therapy/Procedure

4Therapeutics
11/2020 - 08/2000
1Central Venous Catheters
04/2015
1Catheters
10/2014
1Perioperative Care
10/2014
1Secondary Prevention
09/2010